Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert J Motzer
Sunitinib-Associated Hypertension and Neutropenia as Efficacy Biomarkers in Metastatic Renal Cell Carcinoma Patients
British Journal of Cancer
Cancer Research
Oncology
A Case for the Use of Receiver Operating Characteristic Analysis of Potential Clinical Efficacy Biomarkers in Advanced Renal Cell Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
Related publications
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Safety and Efficacy of Sunitinib for Advanced Non-Clear Cell Renal Cell Carcinoma
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Mp16-01 Clinical Implications of Sunitinib and N-Desethyl-Sunitinib Plasma Concentrations for Treatment Outcome in Metastatic Renal Cell Carcinoma Patients
Journal of Urology
Urology
Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma
Current Oncology
Oncology
Efficacy and Safety of Sunitinib Alternate Day Regimen in Patients With Metastatic Renal Cell Carcinoma in Japan: Comparison With Standard 4/2 Schedule
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
